£91k
−20%vs Jul 2024Active10886045Private limited companyNottingham
AMPHARMA SOLUTIONS LIMITED
Significant control: Anil Kumar Govindji Mistry (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Ampharma Solutions Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AMPHARMA SOLUTIONS LIMITED is an active private limited company (company number 10886045) incorporated on 27 July 2017, registered in Nottingham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 July 2025, showing net assets of £91k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 20% on the prior period (£114k).
Peer position · net assets
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Mr Anil Kumar Govindji Mistry
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 27 July 20179 yrs ago
- Next accounts due
- 30 April 2027in 189 days
- Confirmation statement due
- 10 August 2027in 291 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Jul 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | £91k | — | — | £9,422 | — | — | 1 |
| 31 July 2024 | £114k | — | — | £4,893 | — | — | 1 |
Current ratio10.52Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £91,131 at 31 July 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 10.52
- Incorporated five or more years agoIncorporated 27 July 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 291 days
- Next accounts duein 189 days
- Accounts period endNet assets £91k · micro accounts
- Accounts period endNet assets £114k · micro accounts
- Incorporated
08
Similar companies in Nottingham
- AGHOCO 1566 (BIDCO) LIMITEDNottingham · inc. Jul 2017
- EVERGREEN HOLDCO 1 LIMITEDNottingham · inc. Jul 2017
- AGHOCO 1579 (TOPCO) LIMITEDNottingham · inc. Aug 2017
- AGHOCO 1578 (MIDCO) LIMITEDNottingham · inc. Aug 2017
- EVERGREEN HOLDCO 2 LIMITEDNottingham · inc. Aug 2017
- EVERGREEN HOLDCO 3 LIMITEDNottingham · inc. Aug 2017
All companies incorporated on 27 July 2017 · in Jul 2017.
09
Reminders for AMPHARMA SOLUTIONS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.